These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37128919)

  • 21. Proteolysis of Von Willebrand Factor Influences Inflammatory Endothelial Activation and Vascular Compliance in Atherosclerosis.
    Ozawa K; Muller MA; Varlamov O; Tavori H; Packwood W; Mueller PA; Xie A; Ruggeri Z; Chung D; López JA; Lindner JR
    JACC Basic Transl Sci; 2020 Oct; 5(10):1017-1028. PubMed ID: 33145464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ADAMTS13 Retards Progression of Diabetic Nephropathy by Inhibiting Intrarenal Thrombosis in Mice.
    Dhanesha N; Doddapattar P; Chorawala MR; Nayak MK; Kokame K; Staber JM; Lentz SR; Chauhan AK
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1332-1338. PubMed ID: 28495930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formation and Resolution of Pial Microvascular Thrombosis in a Mouse Model of Thrombotic Thrombocytopenic Purpura.
    Adili R; Holinstat M
    Arterioscler Thromb Vasc Biol; 2019 Sep; 39(9):1817-1830. PubMed ID: 31340669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of von Willebrand factor and ADAMTS13 in the no-reflow phenomenon: after primary percutaneous coronary intervention.
    Zhao B; Li J; Luo X; Zhou Q; Chen H; Shi H
    Tex Heart Inst J; 2011; 38(5):516-22. PubMed ID: 22163125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice.
    Chen J; Reheman A; Gushiken FC; Nolasco L; Fu X; Moake JL; Ni H; López JA
    J Clin Invest; 2011 Feb; 121(2):593-603. PubMed ID: 21266777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy.
    Tersteeg C; de Maat S; De Meyer SF; Smeets MW; Barendrecht AD; Roest M; Pasterkamp G; Fijnheer R; Vanhoorelbeke K; de Groot PG; Maas C
    Circulation; 2014 Mar; 129(12):1320-31. PubMed ID: 24449821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular imaging of activated von Willebrand factor to detect high-risk atherosclerotic phenotype.
    McCarty OJ; Conley RB; Shentu W; Tormoen GW; Zha D; Xie A; Qi Y; Zhao Y; Carr C; Belcik T; Keene DR; de Groot PG; Lindner JR
    JACC Cardiovasc Imaging; 2010 Sep; 3(9):947-55. PubMed ID: 20846630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serial changes in von Willebrand factor-cleaving protease (ADAMTS13) and prognosis after acute myocardial infarction.
    Matsukawa M; Kaikita K; Soejima K; Fuchigami S; Nakamura Y; Honda T; Tsujita K; Nagayoshi Y; Kojima S; Shimomura H; Sugiyama S; Fujimoto K; Yoshimura M; Nakagaki T; Ogawa H
    Am J Cardiol; 2007 Sep; 100(5):758-63. PubMed ID: 17719316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of Platelet GPVI Protects Against Myocardial Ischemia-Reperfusion Injury.
    Pachel C; Mathes D; Arias-Loza AP; Heitzmann W; Nordbeck P; Deppermann C; Lorenz V; Hofmann U; Nieswandt B; Frantz S
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):629-35. PubMed ID: 26916731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of von Willebrand factor by ADAMTS13 ameliorates lipopolysaccharide-induced lung injury in mice.
    Onodera Y; Mitani S; Hosoda C; Takabayashi Y; Sakata A; Kawasaki R; Mori R; Ohshima C; Nishio K; Sugimoto M; Soejima K; Mackman N; Shima M; Tatsumi K
    Int J Hematol; 2023 Dec; 118(6):699-710. PubMed ID: 37759076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aging-related early changes in markers of ventricular and matrix remodeling after reperfused ST-segment elevation myocardial infarction in the canine model: effect of early therapy with an angiotensin II type 1 receptor blocker.
    Jugdutt BI; Jelani A; Palaniyappan A; Idikio H; Uweira RE; Menon V; Jugdutt CE
    Circulation; 2010 Jul; 122(4):341-51. PubMed ID: 20625108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Von Willebrand factor and ADAMTS13 in arterial thrombosis: a systematic review and meta-analysis.
    Sonneveld MA; de Maat MP; Leebeek FW
    Blood Rev; 2014 Jul; 28(4):167-78. PubMed ID: 24825749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Size regulation of von Willebrand factor-mediated platelet thrombi by ADAMTS13 in flowing blood.
    Donadelli R; Orje JN; Capoferri C; Remuzzi G; Ruggeri ZM
    Blood; 2006 Mar; 107(5):1943-50. PubMed ID: 16293606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ADAMTS13 gene deletion aggravates ischemic brain damage: a possible neuroprotective role of ADAMTS13 by ameliorating postischemic hypoperfusion.
    Fujioka M; Hayakawa K; Mishima K; Kunizawa A; Irie K; Higuchi S; Nakano T; Muroi C; Fukushima H; Sugimoto M; Banno F; Kokame K; Miyata T; Fujiwara M; Okuchi K; Nishio K
    Blood; 2010 Feb; 115(8):1650-3. PubMed ID: 19965676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Shear stress and von Willebrand factor in health and disease.
    Tsai HM
    Semin Thromb Hemost; 2003 Oct; 29(5):479-88. PubMed ID: 14631548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ADAMTS13: a new link between thrombosis and inflammation.
    Chauhan AK; Kisucka J; Brill A; Walsh MT; Scheiflinger F; Wagner DD
    J Exp Med; 2008 Sep; 205(9):2065-74. PubMed ID: 18695007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced Proteolytic Cleavage of von Willebrand Factor Leads to Aortic Valve Stenosis and Load-Dependent Ventricular Remodeling.
    Ozawa K; Muller MA; Varlamov O; Hagen MW; Packwood W; Morgan TK; Xie A; López CS; Chung D; Chen J; López JA; Lindner JR
    JACC Basic Transl Sci; 2022 Jul; 7(7):642-655. PubMed ID: 35958695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insights Into Immunothrombosis: The Interplay Among Neutrophil Extracellular Trap, von Willebrand Factor, and ADAMTS13.
    Yang J; Wu Z; Long Q; Huang J; Hong T; Liu W; Lin J
    Front Immunol; 2020; 11():610696. PubMed ID: 33343584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of tranexamic acid on endothelial von Willebrand factor/ADAMTS-13 response to in vitro shock conditions.
    Diebel LN; Liberati DM
    J Trauma Acute Care Surg; 2023 Feb; 94(2):273-280. PubMed ID: 36322025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma levels of active Von Willebrand factor are increased in patients with first ST-segment elevation myocardial infarction: a multicenter and multiethnic study.
    Rutten B; Maseri A; Cianflone D; Laricchia A; Cristell NA; Durante A; Spartera M; Ancona F; Limite L; Hu D; Li H; Uren NG; de Groot PG; Mannucci PM; Roest M
    Eur Heart J Acute Cardiovasc Care; 2015 Feb; 4(1):64-74. PubMed ID: 24833640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.